Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of.
Real-world retrospective study showed increased sensitivity for CNSide relative to standard cerebral spinal fluid cytology in detecting leptomeningeal metastases
. | June 5, 2023
Investment Analysts’ new coverage for Tuesday, May 30th: StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS) (TSE:AEZ). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Airgain (NASDAQ:AIRG). StockNews.com issued a buy rating on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Brookfield Asset Management (NYSE:BAM) […]
Biocept, Inc. (NASDAQ:BIOC – Get Rating) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 7,800 shares, a drop of 24.3% from the April 30th total of 10,300 shares. Currently, 1.3% of the company’s stock are short sold. Based on an average daily volume of 97,800 […]
StockNews.com initiated coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research note published on Monday morning. The firm issued a hold rating on the medical research company’s stock. Separately, Maxim Group downgraded shares of Biocept from a buy rating to a hold rating in a research report on Friday, April 14th. Biocept […]